Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
6.19
-0.08 (-1.28%)
At close: Jan 16, 2026, 4:00 PM EST
6.24
+0.05 (0.81%)
After-hours: Jan 16, 2026, 7:55 PM EST
Unicycive Therapeutics Market Cap
Unicycive Therapeutics has a market cap or net worth of $133.03 million as of January 16, 2026. Its market cap has increased by 61.38% in one year.
Market Cap
133.03M
Enterprise Value
90.60M
1-Year Change
61.38%
Ranking
Category
Stock Price
$6.19
Market Cap Chart
Since the IPO on July 13, 2021, Unicycive Therapeutics's market cap has increased from $66.49M to $133.03M, an increase of 100.08%. That is a compound annual growth rate of 16.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 133.03M | 7.28% |
| Dec 31, 2025 | 124.01M | 50.43% |
| Dec 31, 2024 | 82.44M | 173.36% |
| Dec 29, 2023 | 30.16M | 270.11% |
| Dec 30, 2022 | 8.15M | -73.58% |
| Dec 31, 2021 | 30.84M | -53.61% |
| Jul 13, 2021 | 66.49M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |